Ming-Yung Lee

A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study

Keng‐Chang Tsai, Yi-Chia Huang, Chia‐Ching Liaw et al. · Biomedicine & Pharmacotherapy · 2020 · 109 citations · Full text

Medicine, Infectious Diseases, Pharmacology +12

Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study

Chiew-Loon Koo, Lai‐Fong Kok, Ming-Yung Lee et al. · Journal of Translational Medicine · 2009 · 99 citations · Full text

Medicine, Oncology, Pathology +17

Scoring of p16INK4a immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study

Chih‐Ping Han, Lai‐Fong Kok, Po-Hui Wang et al. · Modern Pathology · 2009 · 57 citations

Medicine, Oncology, Pathology +15

Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study

Lai‐Fong Kok, Ming-Yung Lee, Yeu-Sheng Tyan et al. · Archives of Gynecology and Obstetrics · 2009 · 28 citations

Medicine, Oncology, Pathology +16

Five commonly used markers (p53, TTF1, CK7, CK20, and CK34βE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study

Chih‐Ping Han, Lai‐Fong Kok, Ming-Yung Lee et al. · Archives of Gynecology and Obstetrics · 2009 · 20 citations

Medicine, Oncology, Pathology +13